Simian Virus 40 Large T-antigen expressed in NIH3T3 cells increases p53 level and interacts with this tumor suppressor to form large nuclear complexes. We show here that T-antigen sensitizes NIH3T3 cells to low doses of the oxidative stress inducer menadione. This oxidant increased p53 accumulation and disrupted p53/T-antigen interaction, but not T-antigen/pRb, T-antigen/Hsc70 and p53/Hsc70 complexes; a phenomenon inhibited by the anti-oxidant N-acetyl-cysteine. Analysis of several p53 downstream gene products revealed that the level of Fas receptor, which was sharply reduced by T-antigen expression, was drastically increased in response to menadione treatment. Menadione also induced a Tantigen dependent cleavage of Fas ligand. Analysis performed with Fas receptor antagonist antibody and metalloproteinases inhibitor revealed that menadione triggers a Fas-dependent death of a fraction of T-antigen expressing cells. This Fas pathway does not activate caspase 8 or 3, probably because of the inhibition induced by T-antigen, and leads to a necrotic cell death which contributes at least in part to the hypersensitivity of T-antigen transformed cells to oxidative stress.
Introduction
Large tumor antigen (T-antigen) is a 90 kDa nuclear multifunctional phosphopolypeptide encoded by Simian virus 40 (SV40) which is essential for virus growth and cell transformation (Fanning and Knippers, 1992) . In rodent cells, such as NIH3T3 ®broblasts, T-antigen expression induces and maintains a transformation phenotype without the cooperation of other oncogenes (Manfredi and Prives, 1994) by inhibiting the activity of the tumor suppressor polypeptide p53 (Schmieg and Simmons, 1988) . This phenomenon does not require a genetic modi®cation of p53 and correlates with an increase in p53 level (Deppert and Haug, 1986; Moorwood et al., 1996) . T-antigen also binds the retinoblastoma protein pRb, however, this interaction plays only a minor role in the transformation of immortalized NIH3T3 cells (De Caprio et al., 1988; Thompson et al., 1990) . Moreover, T-antigen interacts with other polypeptides such as those implicated in replication or transcription including CBP/p300 and a-polymerase, and with the molecular chaperones Hsp70/Hsc70 (Dornreiter et al., 1992; Eckner et al., 1996; Kelley and Georgopoulos, 1997) . T-antigen also displays pleotropic activities, including helicase, ATPase, and ability to bind DNA (Manfredi and Prives, 1994) which are modulated by post-translational modi®cations and by the interaction of T-antigen with speci®c cellular targets. Posttranslational modi®cations include the ability to form oligomeric structures and to become phosphorylated (Fanning and Knippers, 1992; Klausing and Knippers, 1994) .
Fas/APO-1/CD95 is a member of the TNF/nerve growth factor receptor superfamily (Nagata and Golstein, 1995) which after stimulation by Fas ligand (FasL), either present on cell surface or in the growth medium after cleavage of its extracellular part by speci®c metalloproteinases, induces cell death by apoptosis (Trauth et al., 1989; Kayagaki et al., 1995) . Fas/FasL binding triggers Fas trimerization and procaspase 8 activation (Juo et al., 1998) which in turn activates other caspases, such as caspase 3 (Enari et al., 1996; Kamada et al., 1997) . This activation leads to the cleavage of numerous dierent substrates, including PARP, pRb, lamins and several other polypeptides (reviewed in Stroh and Schulze-Ostho, 1998) , and thus to DNA cleavage and cell death. Of interest, recent observations have drawn a link between cell transformation and Fas and point out a possible mechanism by which cancer cells may escape from the host-mediated immune destruction: (i) the expression of large T-antigen (Rouquet et al., 1995) or other oncogenic proteins such as Ras (Fenton et al., 1998) or adenovirus E1B (Perez and White, 1998) inhibits Fasmediated apoptosis and (ii) several cancer cells have lost their sensitivity to Fas-induced apoptosis (Hahne et al., 1996; Green, 1998; Pitti et al., 1998) .
It has recently been shown that p53 stimulates human Fas synthesis by binding to p53 responsive elements located in the promoter as well as in the ®rst intron of the human fas gene (Owen-Schaub, 1995; MuÈ ller et al., 1998) . p53 also activates the transport of Fas stored in the Golgi apparatus to the cell surface (Bennett et al., 1998) . Hence, p53 activation can mediate apoptosis through Fas by inducing the accumulation of this receptor and by stimulating its transport from the Golgi. In contrast, mutated p53 down-regulates Fas. It is also well documented that anticancer agents such as cisplatin, mitomycin, methotrexate, mitoxantrone, doxorubicin, etoposide and bleomycin, known to increase p53 level, also upregulate Fas and FasL levels and induce a Fas-dependent apoptosis (Friesen et al., 1996; MuÈ ller et al., 1997) . If p53 is mutated or deleted, only FasL upregulation is observed (MuÈ ller et al., 1998) . Taken together, these observations provide a mechanistic explanation of how mutated p53 contributes to resistance to chemotherapeutic drugs.
We have previously shown that NIH3T3 cells transformed by T-antigen or other oncogenes are hypersensitive to heat shock (Fabre-Jonca et al., 1995; Gonin et al., 1997) , a phenomenon which may be the result of altered expression of stress proteins (Fabre-Jonca et al., 1995; Gonin et al., 1997) . We show here that T-antigen transformed NIH3T3 cells are more sensitive to oxidative stress induced by low doses of the quinone menadione than their normal counterparts. In T-antigen transformed cells, menadione induced a rise in p53 level and disrupted the complex formed between T-antigen and p53. We also observed an increase in Fas receptor level and FasL cleavage in these cells. Of interest, the death of T-antigen transformed NIH3T3 cells induced by low doses of menadione was found to depend, at least to a certain extent, on the Fas/FasL system. In T-antigen transformed NIH3T3 cells, oxidative stress, probably via the release of a large amount of p53, favors the activation of Fas via FasL cleavage. Because of the blockage induced by T-antigen, a caspase independent Fas pathway is upregulated which contributes to the necrotic death of the cells and participates in the hypersensitivity of T-antigen transformed cells to oxidative stress.
Results
T-antigen transformation of NIH3T3 fibroblasts correlates with p53 accumulation and increased cytotoxicity to menadione Figure 1A indicates that 3T3-T1 cells contain about twice the level of T-antigen present in 3T3-T2 cells. The 88 and 90 kDa polypeptides detected by T-antigen antibody may represent two dierent phosphoisoforms of T-antigen as described by Paley (1996) . Immunouorescence analysis showed that T-antigen is localized in the nucleus in both 3T3-T1 and -T2 cells (see Figure  4D and Gonin et al., 1997) . The level of p53 was determined next. As seen in Figure 1A , a high level of p53 is detectable in T-antigen transformed cells. 3T3-T1 cells contain about twice as much p53 than 3T3-T2 cells indicating that a direct correlation exists between the level of T-antigen and that of p53.
We next analysed the ability of the dierent cell lines described above to survive to an oxidative stress induced by menadione (Cadenas, 1989) . Following a 16 h exposure to low concentrations of menadione (up to 12 mM), T-antigen expressing 3T3-T1 cells were found to be more sensitive than control 3T3-SP cells, ( Figure 1B) . Similar results were obtained with 3T3-T2 cells, however, in this case, these cells were slightly less sensitive than 3T3-T1 cells for low doses of menadione (up to 8 mM). Higher doses of menadione induced the killing of normal and transformed cells with the same eciency. Analysis was also performed after 4 h of treatment with higher doses of menadione (up to 20 mM). In these conditions, 3T3-T1 and -T2 cells were still more sensitive than normal cells. These eects were no more observed when cells were pretreated with the antioxidant N-acetyl-cysteine (NAC) (data not shown), hence suggesting that the cytotoxicity induced by menadione re¯ects its ability to generate intracellular -T1 and 3T3-T2) cells were exposed 16 h to the indicated concentrations of menadione. Cell survival was determined by crystal violet coloration. The histograms shown are representative of three identical experiments; standard deviations are presented (n=3). (C) Cell death analysis using Annexin V assay. Normal or Tantigen transformed cells were treated or not for 4 h with menadione (20 mM), before being incubated with Annexin-V-FITC (FL1-H) and propidium iodine (FL2-H) and analysed by¯ow cytometry as described in Materials and methods reactive oxygen species (ROS), particularly superoxide anions. Sensitivity of T-antigen transformed NIH3T3 cells was also induced by hydrogen peroxide (24 h, 500 mM), however, the eect was not as drastic as that observed with menadione (data not shown). Hence, 3T3-T cells have a reduced ability to cope with oxidative stress, particularly when it generates intracellular superoxide anions.
The two dimensional FACScan analysis (PI/Annexin V) presented in Figure 1C revealed that a 4 h treatment with 20 mM of menadione generated some annexin V positive 3T3-SP cells suggesting that these cells undergo apoptosis in response to this oxidant. In contrast, T-antigen expressing cells showed a three times more intense death, essentially through a necrotic process. A similar type of result was observed when cells were treated for longer time periods with lower doses of menadione (not shown).
Menadione induces ROS accumulation in T-antigen expressing cells, a phenomenon probably related to the decreased level of detoxifiant enzyme activities in these cells ROS level was estimated by FACS analysis of the intracellular oxidation of hydroethidine in ethidium bromide (Rothe and Valet, 1990; Carter et al., 1994) . No apparent accumulation of intracellular ROS was observed in control 3T3-SP cells exposed 4 h to 20 mM menadione ( Figure 2A ). In contrast, following similar treatment, an eight and ®vefold increase in the level of these reactive species was observed in 3T3-T1 and 3T3-T2 cells, respectively. In view of these results, the activity of several detoxi®ant enzymes, such as catalase, Mn-and Cu-Zn superoxide dismutase (SOD), and glutathione peroxidase was determined in control and T-antigen expressing cells. As seen in Figure 2B , the activity of Cu-Zn SOD, and to a lesser extent that of catalase, was signi®cantly decreased in growing, untreated, T-antigen expressing cells. Hence, the accumulation of abnormal ROS levels in T-antigen expressing cells probably results of de®cient detoxi®ant enzymatic activities.
Menadione increases p53 level and interferes with the redistribution of p53 and T-antigen in the soluble cytoplasmic fraction upon cell lysis In 3T3-SP cells, p53 was not detectable even after menadione treatment. In contrast, 3T3-T1 and -T2 cells contained a high level of p53, which was further increased by a factor of about two in 3T3-T1 cells and 1.5 in 3T3-T2 cells in response to menadione ( Figure  3 ). This p53 increase was not observed when T-antigen expressing cells were pretreated with the antioxidant NAC, suggesting that ROS are responsible for this eect. In contrast, T-antigen transformation and/or menadione treatment did not change the intracellular level of c-myc or pRb (data not shown).
To detect possible intracellular changes in the structural organization of p53 following menadione stimulation, exponentially growing 3T3-T1 and -T2 cells were fractionated in RIPA buer as described in Materials and methods. p53 was then detected in the dierent fractions by immunoblot analysis. Figure 4A shows that the majority of p53 was recovered in the 10 000 g supernatant fraction (s), while the particulate fraction (p) was devoid of this protein. A similar observation was made concerning T-antigen (not shown). A dierent distribution of p53 was observed in cells lyzed after menadione treatment (10 mM for 8 h) since p53 and T-antigen (not shown) were recovered mainly (90%) in the particulate fraction (p) ( Figure 4A ). Similar results were observed when cells were lyzed in TEM buer after extensive douncing (not shown). The inhibition of the redistribution of p53 and T-antigen in the soluble fraction was proportional to the intensity of the oxidative stress. Control experiments showed that Hsp60 was always quantitatively recovered in the supernatant fraction (s). In cells pretreated with NAC before being exposed to menadione p53 ( Figure 4B ) as well as T-antigen (not shown) were only weakly retained in the particulate fraction upon cell lysis. When cell lysis was performed by sonication, a fraction (40 ± 60%, depending on the menadione treatment) of p53 was released in the supernatant fraction ( Figure 4C ).
Control immuno¯uorescence analysis, presented in Figure 4D , shows that p53 and T-antigen are essentially localized in the nucleus of 3T3-T cells and this independently of menadione treatment. Hence, the structural organization of p53 and T-antigen in the nucleus is changed by menadione treatment.
Menadione specifically disrupts T-antigen/p53 complex
We next investigated whether menadione altered Tantigen/p53 interaction. This was assessed in 3T3-T1 cells treated or not for 8 h with 10 mM menadione and lyzed by sonication in TEM buer in order to completely recover T-antigen and p53 in the soluble fraction (see Figure 4C ). In soluble extracts from untreated cells, p53 antibody immunoprecipitated both p53 and T-antigen ( Figure 5A , line i/1). This coimmunoprecipitation was speci®c as it was still observed after extensive washing of the immune complex bound to protein-A-sepharose beads ( Figure  5A , line i/2). Immunoblot analysis of the supernatant after the immunoprecipitation step revealed that more than 90% of p53 was immunoprecipitated and about 75% of the total cellular content of T-antigen coimmunoprecipitated with p53 (line s). When the same analysis was performed with cells exposed to menadione, p53 antibody had lost most of its ability to coimmunoprecipitate T-antigen ( Figure 5A ). Analysis of the p53/T-antigen ratio in the immunoprecipitated fraction suggests that menadione induces the disruption of p53/T-antigen complexes. Indeed, a ratio value of 2.6 was observed for untreated cells while it was of 8.3 after menadione treatment. Similar observations were made when 3T3-T2 cells were analysed or when cells were lyzed in RIPA buer (not shown). In this case, however, a less intense menadione treatment had to be used to allow the extraction of some p53 and T-antigen molecules from the nucleus. When cells were pretreated with NAC, no dissociation of p53/T-antigen complexes was induced by menadione (not shown).
The interaction of T-antigen with pRb and Hsc70 was also investigated. As seen in Figure 5B , C.1, the binding of T-antigen to pRb or Hsc70 was not signi®cantly altered by menadione. A similar observation was made for the complex containing p53 and Hsc70 ( Figure 5C .2). This suggests that the decreased interaction between p53 and T-antigen following menadione treatment is speci®c.
Changes in the native size of T-antigen and p53 induced by menadione treatment
The native molecular mass of T-antigen, p53 and pRb in control and menadione treated cells (10 mM, 8 h) was determined after cell lysis in TEM buer containing 0.1% Triton X-100 and loading the 10 000 g supernatant onto a sepharose 6B gel ®ltration column (see Materials and methods). In untreated 3T3-T1 cells, T-antigen forms very large oligomeric structures that were recovered in the exclusion volume of the column (molecular mass 42.10 6 Da). p53 showed a similar distribution, hence suggesting that both proteins were in the form of huge nuclear complexes ( Figure 5D ). Similar results were observed when cells were lyzed in RIPA buer (not shown). After menadione treatment, these two polypeptides still formed heterogeneous complexes but their size (between 700 to 10 6 kDa) was nevertheless smaller than that observed in untreated cells.
Analysis of pRb showed that this polypeptide had an heterogeneous native size comprised between 200 and 700 kDa ( Figure 5E ). Hence, only a small fraction (5 ± 10%) of pRb had a native mass similar to T-antigen and could therefore be complexed to this protein. No change in the native size distribution of pRb was observed after menadione treatment.
Fas receptor accumulation and FasL cleavage induced by menadione in T-antigen transformed cells
Since menadione disrupts the interaction between Tantigen and p53, we therefore tested if this phenomenon induced p53 to regain its ability to transactivate target genes, such as those encoding p21, Bax and Fas (El-Deiry et al., 1993; Miyashita and Reed, 1995; Owen-Schaub et al., 1995; MuÈ ller et al., 1998) . p21, which was not detectable in untreated cells, drastically accumulated in response to menadione. However, no dierence in p21 inducibility was detected between normal and T-antigen transformed cells (not shown). Figure 3 Analysis of p53 levels in normal and 3T3-T cells exposed or not to menadione. 3T3-SP or T-antigen transformed (3T3-T1 and 3T3-T2) cells were either kept untreated (line 1) or treated with 10 mM menadione for 9.5 h (line 2) or 16 h (line 3). Cells were also treated with 10 mM NAC before being exposed to 10 mM menadione during 16 h (line 4). In each case, total cellular proteins (20 mg) were analysed in immunoblots probed with antip53 serum. Autoradiograph of an ECL-revealed immunoblot is presented. Note that p53 level increases during menadione treatment in T-antigen transformed cells; a phenomenon prevented by NAC Concerning Bax, the results were not conclusive since this polypeptide was not detectable by conventional immunoblotting techniques. In spite of the fact that it
is not yet known if murine fas gene contains p53 binding elements, the level of Fas receptor was also investigated. Figure 6A shows that T-antigen mediated transformation reduced the level of Fas receptor, an eect which was more intense in 3T3-T1 cells (0.66 instead of 1) than in 3T3-T2 cells (0.82 instead of 1), suggesting that this phenomenon is proportional to the level of T-antigen and p53. T-antigen transformation also led to an increase in Fas receptor level when cells were exposed to 15 mM menadione. By 8 h of treatment, the level of Fas receptor in 3T3-T2 cells was almost identical to that observed in control untransformed cells. In 3T3-T1 cells, which originally contained less Fas receptor than 3T3-T2 cells, the rise was of similar intensity, but the level which was reached after 8 h of menadione treatment was still below that observed in control cells. As a control, no (B) NAC abolishes the nuclear retention of p53 induced by menadione. As in (A) but 3T3-T1 and 3T3-T2 cells were either incubated 8 h in the presence of 10 mM menadione (1) or exposed to a pretreatment of 1 h with 10 mM of NAC before being exposed to menadione (2). (C) Analysis of p53 and T-antigen subcellular localizations in cells lyzed by sonication. In this case, 3T3-T1 cells were either untreated (line 1) or treated with 10 mM of menadione for 8 h (line 2) before being sonicated in TEM buer and centrifuged as described in Materials and methods. The presence of p53 and T-antigen in resulting particulate (p) and soluble (s) fractions was analysed as above. (D) Immuno¯uorescence analysis of p53 and T-antigen cellular localization. 3T3-T1 cells, either untreated or treated with 15 mM menadione for 4 h, were ®xed, incubated with either anti-T-antigen or -p53 antibodies and processed as described in Materials and methods. Bar: 10 mm changes in Fas level were observed when cells were heat shock treated for 90 min at 43 or 448C (data not shown). These observations suggest that oxidative stress speci®cally stimulates the expression of Fas receptor in 3T3-T cells. In spite of the drastic decrease in the total level of Fas mediated by T-antigen expression, the level of Fas at the cell surface was not altered ( Figure 6B ). After menadione treatment surface Fas expression could not be studied, since this oxidant induced some cell permeabilization. Concerning Fas ligand (FasL), Figure 6C shows that the level of this 38 kDa protein was not altered by Tantigen expression. After menadione treatment, a decrease in FasL level was observed in 3T3-T1 and -T2 cells but not in normal 3T3-SP cells. This eect, which was inhibited by NAC, may re¯ect an enhanced maturation of 38 kDa FasL leading to the production of soluble FasL (29 kDa). Moreover, the disappearance of FasL was not observed when cells were heat shock treated for 90 min at 438C (not shown), hence suggesting that it is speci®c to oxidative stress.
Fas dependent, caspase independent, cell death induced by menadione in T-antigen transformed cells
Since menadione induces Fas receptor accumulation and the disappearance of FasL in T-antigen expressing cells, we analysed the eect of a Fas antagonist antibody on the cell death induced by menadione. Non con¯uent cells were therefore incubated for 1 h with 500 ng/ml of Fas antagonist antibody before being exposed to 10 mM menadione for 8 h ( Figure 7A ) or 16 h ( Figure 7B) . Figure  7A ,B shows that Fas antagonist antibody slightly increased the percentage of 3T3-SP cells that survived to menadione treatment. The eect was more intense in the case of 3T3-T2 cells suggesting that menadione induces a fraction of these cells to ) and (E) 3T3-T1 cells, treated or not during 8 h with 10 mM of menadione, were lyzed in TEM buer containing 0.1% Triton X-100 and the 10 000 g lysates were loaded onto sepharose 6B gel ®ltration column as described in Materials and methods. The presence of T-antigen, p53 (D) and pRb (E) in the fractions eluted of the column was detected in immunoblots probed with anti-T-antigen, anti-p53 or anti-pRb antibodies. Arrows indicate the apparent size (kDa) of gel ®ltration markers (E: exclusion volume, 2.10 6 Da) die through a Fas receptor dependent pathway. The Fas antibody antagonist also induced some protection in the case of 3T3-T1 cells, but the eect was not as intense as that observed in the case of 3T3-T2 cells. Moreover, the protective eect of Fas antagonist antibody was more intense after 8 h than after 16 h of treatment. These results favor the hypothesis that menadione stimulates the cleavage of the 38 kDa FasL polypeptide leading to the formation of soluble FasL which triggers an autocrine or exocrine Fas-dependent pathway. This pathway appears to induce the death of at least a fraction of the transformed cells, particularly 3T3-T2 cells.
The cleavage of the 38 kDa FasL polypeptide by metalloproteinases can be inhibited by 1, 10 phenanthroline. As seen in Figure 8A , a 1 h treatment with 10 or 15 mM of this product eciently inhibited the disappearance of the 38 kDa FasL polypeptide in response to menadione. This suggests that menadione triggers the cleavage of FasL. We next analysed the eect mediated by 1, 10 phenanthroline on the cell death of 3T3-T1 and -T2 cells exposed to menadione. Crystal violet survival and cell morphology analysis are presented in Figure 8B ,C, respectively. Despite the weak toxicity of 1, 10 phenanthroline, this product induced a strong protective eect against menadione.
Taken together, these results suggest that part of the necrotic cell death process mediated by menadione in 3T3-T cells (particularly 3T3-T2 cells), is Fas dependent and may therefore rely on the release of soluble FasL by the stressed cells.
The activity of pro-caspase 8 and 3 was analysed next. In 3T3-T cells exposed to 15 mM of menadione, the activity of both caspases was decreased (instead of being increased) ( Figure 9A,B) . The eect was particularly intense in the case of caspase 8. In contrast, a slight increased activity of these caspases was observed in control 3T3-SP cells after 7 ± 8 h of treatment with 15 mM of menadione. NAC inhibited these eects. These results suggest that the necrotic death of T-antigen-expressing cells induced by menadione is caspase 8 and 3 independent.
Gradual inhibition of the apoptotic death induced by Fas antibody agonist in NIH3T3 cells expressing increasing levels of T-antigen
A phase contrast morphological analysis of 3T3-SP, -T1 and -T2 cells exposed for 2 h to either 62.5, 250 or 500 ng/ml of a Fas agonist antibody in the presence of 10 ng/ml of actinomycin D is presented in Figure 10 . This experiment clearly demonstrates that control NIH3T3 cells can undergo normal apoptosis when Experiments were performed as in (A) excepted that the immunoblots were probed with an antibody speci®c to the intracellular part of 38 kDa FasL they are exposed to a Fas activator. This eect was strongly attenuated in 3T3-T1 cells and only delayed in 3T3-T2 which express about half of the cellular content of T-antigen present in 3T3-T1 cells. Hence, as already described by Rouquet et al. (1995) , T-antigen can block the Fas pathway, a phenomenon dependent on the level of T-antigen expressed in cells.
Discussion
The mechanism by which T-antigen alters the ability of NIH3T3 cells to detoxify intracellular ROS is unknown, but could be related to the fact that the transformation process often alters the activity of several detoxifying enzymes (Bravard et al., 1993; Sompayrac, 1997) . This hypothesis was con®rmed here by showing that T-antigen expression decreases the activity of Cu-Zn superoxide dismutase and catalase.
When T-antigen transformed cells were exposed to oxidative stress, we observed that: (i) the level of p53 was further increased; and (ii) T-antigen/p53 complexes were speci®cally disrupted, generating a large amount of p53 which remained trapped in the nucleus following cell lysis. These phenomena were probably a result of the drastic burst of intracellular ROS generated by menadione, since they were not observed when cells were pretreated with NAC. Disruption of p53/T-antigen complex is not unique to oxidative stress as DMSO induces a similar eect in SV40 transformed human keratinocytes (Koike et al., 1996) . On the other hand, heat shock, which dephosphorylates pRb, preferentially disrupts pRb/T-antigen complexes (Khandjian, 1995) . p53 ability to transactivate genes has been described to be strongly reduced when this protein is complexed in large structures (Kristjuhan et al., 1998) . We therefore made the assumption that a disruption of p53 complexes could generate p53 molecules that had a higher activity to transactivate target genes. Of interest, we report here important changes in Fas expression in T-antigen transformed cells. First, we observed that Tantigen expression decreased the total cellular content of Fas as compared to normal cells. This phenomenon is probably a consequence of a reduced transcription of the fas gene due to the inability of p53 to transactivate this gene when it is bound to T-antigen. We also show that similar levels of Fas were observed at the cell surface of normal and transformed cells, hence suggesting that the inactivation of p53 by T-antigen did not alter the intracellular tracking of Fas. Of interest, a decrease in the level of Fas receptor has been reported in various tumorigenic cells which probably represents an important mean for these cells to escape to the immune surveillance and cell death (Butler et al., 1998; von Reyer et al., 1998) . Second, following exposure to menadione, the level of Fas drastically increased in 3T3-T cells but not in control 3T3-SP cells. This increase may be a consequence of the ROSmediated disruption of p53/T-antigen complexes which releases large amounts of p53 molecules that could transactivate fas gene. Since Fas tracking from the golgi to the cell surface has been reported to be stimulated by p53 activation (Bennett et al., 1998) , it cannot be excluded that menadione may also enhance the number of Fas receptors at the surface of 3T3-T cells.
Concerning the 38 kDa FasL polypeptide, we concluded that T-antigen transformation did not signi®cantly alter the total level of this protein, while menadione drastically reduced its cellular content in 3T3-T cells; a phenomenon which was again proportional to the level of T-antigen present in the cells. Several lines of evidence support the hypothesis that the disappearance of the 38 kDa FasL polypeptide induced by menadione does not result of an inhibition of the expression of this protein but of its cleavage by metalloproteinases. First, oxidative stress has been reported to increase, instead of to decrease, the level of FasL mRNA. This results in the well-known activation of the transcription factor NF-kB by ROS (Schreck et al., 1992; Kretz-Remy et al., 1996) and to the fact that the promoter of FasL gene contains a kB site (Bauer et al., 1998) . Second, menadione cytotoxicity was found to be partially inhibited by a Fas antagonist antibody suggesting that menadione induces the release of soluble FasL as a consequence of the cleavage of the 38 kDa FasL protein. Third, FasL down-regulation induced by menadione was inhibited by pretreating the cells with 10 ± 15 mM of the metalloproteinases inhibitor 1, 10 phenanthroline. This compound is a potent inhibitor of FasL cleavage, however, at high doses (up to 50 mM) it can also act as a metal chelator which can decrease the formation of ROS (Abello et al., 1994; Bessho et al., 1994; Mariani et al., 1995) . Our results therefore support the hypothesis that, in T-antigen transformed cells, menadione triggers the cleavage of the 38 kDa FasL polypeptide leading to the release in the extracellular medium of soluble FasL. This phenomenon may therefore have hidden a putative NF-kB dependent increase in the expression of FasL mediated by the intense ROS burst observed in 3T3-T cells exposed to menadione.
When menadione treatment was performed in presence of a Fas antagonist antibody or in presence of 1, 10 phenanthroline cell survival was partially preserved, particularly in 3T3-T2 cells. In spite of possible side eects (i.e. metal chelator) of 1, 10 phenanthroline (Hainaut et al., 1995; Verhaegh et al., 1998) , our observations nevertheless suggest, in particular if the experiment using Fas antagonist antibody is considered, that part of the death induced by menadione in 3T3-T2 cells is Fas-dependent. Concerning 3T3-T1 cells, only a small fraction of these cells died through a Fas-dependent phenomenon. This reduced eciency of the Fas system may be a consequence of the fact that, in 3T3-T1 cells, the burst of ROS generated by menadione was far more drastic than the one occurring in 3T3-T2 cells. This elevated level of ROS could have altered cellular functions such as the activity of the Fas/FasL system. Indeed, a high load of superoxide anions has been reported to inhibit Fas-mediated cell death (Clement and Stamenkovic, 1996) . Moreover, it is not excluded that other receptors of the TNF family whose expression is regulated by p53, such as killer/DR5, may also play a role in this phenomenon. It is also important to note that the interference of the Fas signaling pathway mediated by T-antigen (Rouquet et al., 1995) should be theoretically more eective in 3T3-T1 cells than in 3T3-T2 cells because of the higher level of T-antigen in 3T3-T1 cells. (1) or treated for 16 h with 10 mM (3) or 15 mM (6) of menadione. 3T3-T1 cells were also treated for 16 h with 10 mM (2) or 15 mM (5) of menadione in the presence of 10 mM of 1, 10 phenanthroline which was added to the culture medium 1 h before menadione. (4) and (7): similar experiment as (2) (5) but in the presence of 15 mM of 1, 10 phenanthroline. Samples were analysed in immunoblots probed with antiFas ligand antibody. (B) Eect of 1, 10 phenanthroline on the survival of 3T3-T1 (dark hatching) and 3T3-T2 (light hatching) exposed to menadione. (1) cells maintained in normal conditions; (2) cells treated for 16 h with 10 mM of 1, 10 phenathroline; (3) cells treated for 16 h with 10 mM menadione; (4) cells pretreated for 1 h with 10 mM of 1, 10 phenanthroline before being exposed to 10 mM of menadione for 16 h. The relative survival was determined as described in Materials and methods by crystal violet coloration. The histograms shown are representative of three identical experiments; standard deviations are presented (n=3). (C) Phase contrast analysis of 3T3-T1 and -T2 cells exposed 16 h to 10 mM of menadione in the presence or not of 1, 10 phenanthroline (10 mM) added 1 h before menadione to the culture medium. Bar: 10 mm
The mechanism responsible for the interference of the Fas pathway by T-antigen is unknown but may implicate protein kinase C (Rouquet et al., 1995) . Another hypothesis is based on the fact that T-antigen may act as FLIP, an endogenous inhibitor of FLICE/ caspase 8 (Scadi et al., 1999) .
The death induced by menadione in 3T3-T2 cells is necrotic, despite of the fact that part of this phenomenon is, at least in part, Fas-dependent. Indeed, no stimulation of caspases 8 and 3 was induced by menadione. We also observed that speci®c caspase inhibitors (VAD-FMK and DEVD-fmk) did not enhance the survival of 3T3-T cells to menadione treatment (not shown). Moreover, cytochrome c, which triggers the activation of the caspases cascade, did not appear to be speci®cally released from mitochondria in cells exposed to menadione treatment (data not shown). An interesting possibility to be addressed in future studies could be that, in 3T3-T cells exposed to menadione, the level of ATP required to activate an apoptotic cascade (Eguchi et al., 1997) was too low. Our results therefore suggest that, in 3T3-T cells, menadione activates the Fas/FasL system probably because of the release of high level of active p53. However, because of the inhibition of the classical caspasedependent Fas pathway by T-antigen or indirectly by the T-antigen-dependent production of ROS, a Fas necrotic pathway is brought to light after menadione treatment. Of interest, caspase inhibitors can induce a necrotic death of L929 cells expressing human Fas when they are exposed to a Fas agonist antibody (Vercammen et al., 1998) . A similar eect of caspases inhibitors has been described by Lemaire et al. (1998) . Another example concerns the c-myc dependent apoptosis which requires functional p53 and implicates the Fas/APO-1 signaling pathway. Inhibition of caspase activities in these conditions do not increase cell survival but induces a new type of Fas-dependent cell death process (McCarthy et al., 1997; Hueber et al., 1997) . Hence, our results con®rm the existence of two dierent pathways originating from the Fas receptor: one which rapidly leads to apoptosis and, if this pathway is blocked by T-antigen or caspase inhibitors, a second one directing toward a necrotic pathway.
Materials and methods

Cell lines
The obtention and characterization of T-antigen transformed NIH3T3 ®broblasts have already been described (Gonin et al., 1997) . Two clones were obtained that express dierent levels of T antigen (3T3-T1 and 3T3-T2 cells). Cells transfected with the plasmid bearing the hygromycine resistance gene alone were used as control non transformed cells (3T3-SP cells). Cells were grown in Dulbecco's modi®ed medium (DMEM) containing 5% fetal calf serum (Gibco BRL, Cergy Pontoise, France) and 50 mg/ml of Hygromycine B (Sigma, St Louis, MO, USA), at 378C in 5% CO 2 .
Reagents
Anti-T-antigen, -pRb, -p21, -Hsp60, -Hsp70, Fas receptor and ligand antibodies were obtained from Santa Cruz Biotechnology-Tebu (Le Perray-en-Yvelines, France). AntiFasL antibody was directed against the intracellular part of FasL. Anti-Fas receptor antibody used in cytometry as well as Fas agonist antibody used in survival analysis were purchased from Becton Dickinson (Meylan, France). Antip53 antibody (clone pAb122 which recognizes normal and mutated p53) was a gracious gift from Dr May (Fontenay aux Roses, France). Goat anti-mouse and goat anti-rabbit immunoglobulins conjugated to horseradish peroxidase were obtained from Amersham Corp (Buckinghamshire, UK). Goat anti-mouse or anti-hamster immunoglobulins conjugated to¯uorescein isothiocyanate were obtained from Santa Cruz Biotechnology-Tebu (Le Perray-en-Yvelines, France) and from Vector Laboratories (Burlingame, CA, USA), respectively. Fas receptor antagonist antibody was from Alexis (COGER S.A., Paris, France). Crystal violet, menadione, N-Acetyl Cysteine (NAC), 1, 10 Phenanthroline, propidium iodide, Protein A sepharose CL 4B, Sepharose 6B gel ®ltration, and actinomycin D were purchased from Sigma (St Louis, MO, USA). Dihydroethidine was from BioprobeInterchim (MontlucË on, France). Annexin V Fluos staining kit was from Boehringer Mannheim (Meylan, France). Fluorometric and colorimetric Apoalert assay kits for measurement of caspase 8 and 3 activities were obtained from Clontech (Montigny le Bretonneux, France).
Treatment conditions
Twenty hours before menadione treatment, cells were plated in dishes or 96 well plates, to obtain about 80% of con¯uence. Figure 9 Analysis of caspase 8 and 3 activities in cells exposed to menadione. Control 3T3-SP and T-antigen transformed 3T3-T1 and -T2 cells were exposed to 15 mM menadione during various time periods. Cells were also pretreated 1 h with NAC (10 mM) before being exposed to menadione. The activity of two dierent caspases was determined using the colorimetric substrate DEVD-pNA for caspase 3 (B) and the¯uorimetric substrate IETD-AFC in the case of caspase 8 (A). Activation Index was determined as the ratio between the activity determined in extracts of treated versus untreated cells. The histogram shown is representative of one typical experiment. Three independent experiments were performed which gave similar results (variations less than 5%)
Menadione was added to growth medium at a concentration comprised between 8 and 20 mM. All treatments were performed at 378C in DMEM medium containing 5% FCS. In the case of experiments involving NAC, cells were treated for 1 h with 10 mM of this reagent before adding menadione to the growth medium. For survival analysis in the presence of Fas receptor antagonist antibody or metalloproteinases inhibitor, cells were pretreated with these components 1 h before adding menadione to the growth medium.
Cell survival analysis
Crystal violet coloration Cells, plated at a density of 7.5 10 3 per well in 96-well tissue culture plates (Nunc, Rockskilde, Denmark), were grown for 20 h in DMEM containing 5% FCS. After treatment, the growth medium was discarded and the remaining viable cells were washed with phosphate buered saline PBS (8.7 mM Na 2 HPO 4 , 1.5 mM KH 2 PO 4 , 1.5 mM NaH 2 PO 4 , 2.7 mM KCl, 137 mM NaCl) before being exposed for 15 min to a staining medium made of 0.5% crystal violet diluted in a 50% methanol solution. After staining, plates were rinsed and dried. The stained cells were solubilized in a medium containing 0.1 M citrate sodium pH 4.2, 20% methanol and the absorbance of each well was read at 570 nm with a MR 5000 micro-elisa reader (Dynatech Laboratories, Chantilly, VA, USA). The percentage of cell survival was de®ned as the relative absorbance of treated versus untreated cells.
Annexin V assay Analysis of phosphatidyl serines (PS) on the outer lea¯et of apoptotic cell membranes was performed by using Annexin V. (Vermes et al., 1995) . Propidium iodide (PI) was used to dierentiate apoptotic from necrotic cells. 10 6 cells/ 100 mm dishes were plated one day before menadione treatment. Cells were harvested, washed with a phosphate buered saline PBS and 5. 10 5 cells/ml were incubated for 10 min with Annexin V-FITC in binding buer (10 mM HEPES/NaOH, pH 7.4; 140 mM NaCl and 2.5 mM CaCl 2 ). Thereafter, cells were washed and resuspended in binding buer containing 1 mg/ml of propidium iodide. Cell death analysis was performed using a FACS Scan¯ow cytometer (Becton Dickinson, Le pont de Claix, France). Annexin V-FITC and PI related¯uorescences were recorded using FL1-H and FL2-H ®lters, respectively.
Morphological analysis Cell morphology of live cells was analysed with a Nikon inverted photomicroscope equipped with phase contrast. Photographs were recorded onto Ilford HPS 400 ®lm.
Fluorescent measurement of intracellular ROS in vivo
The intracellular content of ROS in living cells was measured with the¯uorescent probe, dihydroethidine (HE) (Rothe and Valet, 1990; Carter et al., 1994) . Brie¯y, 10 6 cells plated in 100 mm falcon dishes 1 day before analysis, were harvested after treatment, washed with PBS and incubated with 40 mg/ ml of HE during 10 min at 378C. Flow cytometry analysis was performed using a FACS Scan¯ow cytometer with excitation and emission wavelengths at 488 nm and 610 nm, respectively (FL2-H ®lter).
Enzymatic assays
Catalase and glutathione peroxidase activities were determined according to Aebi (1984) and Mannervik (1985) , respectively. Manganese (MnSOD) and copper/zinc (Cu- Figure 10 Phase contrast analysis of cells exposed to Fas agonist antibody. Control 3T3-SP and T-antigen transformed 3T3-T1 and -T2 cells were exposed to dierent concentrations of Fas agonist antibody in the presence of 10 ng/ml actinomycin D to potentiate the killing ability of Fas. After 12 h of treatment live cells were photographed using a phase contrast equipped Nikon TMS photomicroscope as described in Materials and methods. Bar: 10 mm ZnSOD) superoxide dismutase activities were measured as described in Parat et al. (1998) by monitoring the rate of the oxidation of pyrogallol by superoxide radicals.
Measurement of DEVD-pNA and IETD-AFC cleavage activity
Cells (2.10 6 for the colorimetric test and 10 6 in the case of uorimetric assay) were harvested and subsequently washed twice in ice-cold PBS, pH 7.4. Cells were then pelleted at 200 g for 5 min and the dry cell pellets were stored at 7808C. DEVD-pNa activity was determined using the apoptosis Alert CPP32 colorimetric assay kit. Reading was at 405 nm in a MR 500 MicroElisa reader (Dynatech Laboratories, Chantilly, VA, USA). IETD-AFC activity was determined using the apoptosis Alert FLICE¯uorimetric assay kit. Excitation was at 400 nM and emission at 505 nM in a Victor Wallach cyto¯uorimeter (EG&G Instruments, Evry, France).
Cell lysis
Cells (7.5 10 5 ) were scraped from the dish in PBS and lyzed according to two dierent protocols. (i) Lysis in RIPA buer (50 mM Tris-HCl, pH 8; 150 mM NaCl; 1% NP40; 0.5% deoxycholate and 0.1% SDS) was performed at 48C by vortexing during 30 min. (ii) Lysis by sonication. In this case, cells were resuspended in TEM buer (20 mM Tris-HCl, pH 8.75; 350 mM NaCl; 0.5 mM MgCl 2 and 0.1 mM EDTA) and sonicated at 48C (®ve pulsations of 5 s each; amplify 60) using a Vibra Cell sonicator (Bioblock Scienti®c, Illkirch, France). In each case, the lysates were clari®ed at 10 000 g during 10 min. Pellets and supernatants were then resuspended in Laemmli sample buer before analysis by SDS page and immunoblotting.
Immunoprecipitation Cells (7.5 10 5 ) were lysed by sonication in TEM buer (see above). The lysates were clari®ed and aliquots of the supernatant were collected and boiled in Laemmli SDS buer. Immunoprecipitation was carried out by incubating cell lysates for 3 h on ice with either T-antigen or p53 antisera. Incubation with protein A Sepharose CL 4B (Sigma, St Louis, MO, USA) was for 1 h on a roller system maintained at 48C. Thereafter, protein A-immunocomplexes were washed or not for three times in TEM buers, and boiled in Laemmli SDS buer. The protein A sepharose was eliminated by centrifugation and the samples were analysed by electrophoresis and immunoblotting.
Gel filtration analysis
Cells (10 7 ), rinsed and scraped in PBS, were lyzed in TEM buer (20 mM Tris-HCl, pH 7.4; 20 mM NaCl; 5 mM MgCl 2 ; 0.1 mM EDTA) containing 0.1% Triton X-100 by douncing with grade B potter. The lysates were clari®ed by centrifugation at 10 000 g for 10 min and the supernatants were applied to a sepharose 6B gel ®ltration column (1 cm6100 cm) equilibrated and developed in lysis buer devoid of Triton X-100. The fractions eluting of the column were resuspended in Laemmli sample buer and analysed by one dimensional Western blot. Molecular mass markers included Blue Dextran (42000 kDa), Thyroglobulin (669 kDa), Apoferritin (443 kDa), b-amylase (200 kDa), Bovine Serum Albumin (66 kDa) and Carbonic Anhydrase (29 kDa).
Gel electrophoresis and immunoblotting
One or two dimensional immunoblots were performed as previously described (Arrigo, 1990) . Primary antibodies were detected with either goat anti-mouse (for T-antigen, p53 and Hsp70) or goat anti-rabbit (for pRb, Hsp60, Fas receptor and Fas ligand) immunoglobulins conjugated to horseradish peroxidase. Immunoblots were revealed with the ECL Kit of Amersham Corp (Buckinghamshire, UK) and autoradiographs were recorded onto X-Omat AR ®lms (Eastman Kodak Co). A Biopro®l system (Vilber Lourmat, France) was used for quanti®cation. Analysis was performed within the range of proportionality of the ®lm. For reprobing, the membranes were incubated for 30 min at 508C in the stripping buer: 100 mM 2-mercaptoethanol, 2% SDS, 62.5 mM Tris-HCl pH 6.7.
Flow cytometry analysis of cell surface Fas receptor 10 6 cells, plated in 100 mm dishes one day before analysis, were harvested, washed with PBS and then incubated for 45 min on ice with anti-Fas receptor diluted 1/50 in PBS containing 1% bovine serum albumin (BSA). Following a washing step in PBS, cells were incubated for 45 min on ice with goat anti-hamster antibody coupled to¯uorescein isothiocyanate (FITC), diluted 1/50 in PBS containing 1% BSA. In each case, controls were performed by incubating cells with only the second antibody. Analysis was performed using a FACS Scan Flow cytometer (Becton Dickinson, Le pont de Claix, France). Fluorescence was recorded using the FL1-H ®lter.
Indirect immunofluorescence analysis
10
5 cells were seeded on glass cover-slips and allowed to grow for 24 h before treatment. Fixation was performed for 30 min at room temperature with a solution containing 3.7% formaldehyde in PBS followed by a 1 min permeabilization step with 0.1% Triton-X100. p53 and T-antigen antibodies were diluted 1/100 in PBS containing 1% BSA. Goat antimouse immunoglobulins coupled to¯uorescein isothiocyanate (FITC) were used as secondary antibody and diluted 1/ 200 in PBS 1% BSA. The stained cells were examined and photographed using appropriate ®lters with a Zeiss Axioskop photomicroscope equipped with a planopo 636 (1 : 3 NA) lens. Fluorescent images were recorded onto Ilford HP5 400 ®lm.
Abbreviations ROS, reactive oxygen species; NAC, N-acetyl-cysteine.
